The development of nanovaccines that employ polymeric delivery carriers has garnered
substantial interest in therapeutic treatment of cancer and a variety of infectious diseases …

In the design of vaccine generation, significant attempts have been made to produce novel
vaccines and, as well, to increase the effectiveness of available vaccines versus particular …

The field of regenerative engineering relies primarily on the dual technical platforms of cell
selection/conditioning and biomaterial fabrication to support directed cell differentiation. As …

Nanovaccines have gathered significant attention for their potential to elicit tumor-specific
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …

Tumor vaccine therapy, which can induce tumor antigen-specific cellular immune responses
to directly kill tumor cells, is considered to be one of the most promising tumor …

Cancer vaccines hold considerable promise for the immunotherapy of solid tumors.
Nanomedicine offers several strategies for enhancing vaccine effectiveness. In particular …

Cancer vaccine efficacy is limited by the immunosuppressive nature of the tumor
microenvironment created by inflammation, immune inhibitory factors, and regulatory T cells …

The clinical translation of many biomolecular therapeutics has been hindered by
undesirable pharmacokinetic (PK) properties, inadequate membrane permeability, poor …

Vaccines based on protein antigens have numerous advantages over inactivated
pathogens, including easier manufacturing and improved safety. However, purified antigens …

An attractive type of cancer immunotherapy is cancer therapeutic vaccines that induce
antitumor immunity effectively. Although supportive results in the recent vaccine studies …